49 Wealth Management, LLC Annexon, Inc. Transaction History

49 Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$4.33 - $6.79 $13,778 - $21,605	-3,182 Reduced 23.94%	10,111 $51.1 Million
Q1 2024 May 07, 2024	SELL	$4.03 - $7.81 $11,288 - $21,875	-2,801 Reduced 17.4%	13,293 $88.1 Million
Q4 2023 May 07, 2024	BUY	$1.63 - $4.63 $26,233 - $74,515	16,094 New	16,094 $73.1 Million

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $245M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of 49 Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 49 Wealth Management, LLC with notifications on news.